Symbols / KTTA Stock $0.69 +0.10% Pasithea Therapeutics Corp.
KTTA (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Ratings
Current target
$0.69
Low
$3.00
High
$3.00
Mean
$3.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-20 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2025-12-08 | init | HC Wainwright & Co. | — → Buy | $3 |
- Funicular Funds (KTTA) reports 1.84M shares, 7.4% stake in Pasithea (KTTA) - Stock Titan Wed, 22 Apr 2026 18
- Pasithea Therapeutics Stock (KTTA) Opinions on PAS-004 Drug Updates | KTTA Stock News - Quiver Quantitative Mon, 01 Dec 2025 08
- KTTA Reiterated by HC Wainwright & Co. -- Price Target Maintained at $3.00 - GuruFocus Mon, 20 Apr 2026 23
- Positive Signs As Multiple Insiders Buy Pasithea Therapeutics Stock - simplywall.st Wed, 25 Mar 2026 07
- ALTMW Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI Sat, 25 Apr 2026 08
- Why Did KTTA Stock Soar A Whopping 43% Today? - Stocktwits hu, 05 Mar 2026 08
- Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock - Yahoo Finance ue, 02 Dec 2025 08
- Is Pasithea Therapeutics (KTTA) Stock Good for Passive Investors | Price at $0.76, Down 0.52% - Crowd Trend Signals - Cổng thông tin điện tử Tỉnh Sơn La hu, 09 Apr 2026 07
- Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares - Investing.com Mon, 01 Dec 2025 08
- Pasithea Therapeutics (Nasdaq: KTTA) raises $60M, extends cash runway into 2028 - Stock Titan ue, 02 Dec 2025 08
- Insider Purchase: Chief Executive Officer of $KTTA Buys 33,333 Shares - Quiver Quantitative Mon, 01 Dec 2025 08
- Pasithea Therapeutics stock plunges after Phase 1 interim data release - Investing.com hu, 20 Nov 2025 08
- Coastlands Capital reveals KTTA (NASDAQ: KTTA) stake in shares and pre-funded warrants - Stock Titan Sat, 18 Apr 2026 02
- Pasithea Therapeutics (Nasdaq: KTTA) prices 80M shares at $0.75, extending cash runway through 1H 2028 - Stock Titan Fri, 28 Nov 2025 08
- KTTA SEC Filings - Pasithea Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan ue, 31 Mar 2026 23
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Cost Of Revenue |
|
—
|
—
|
—
|
0.11
|
| Reconciled Cost Of Revenue |
|
—
|
—
|
—
|
0.11
|
| Gross Profit |
|
—
|
—
|
—
|
0.37
|
| Operating Expense |
|
20.86
+46.37%
|
14.25
-10.82%
|
15.98
+26.93%
|
12.59
|
| Research And Development |
|
7.98
+10.87%
|
7.20
-11.14%
|
8.10
+203.92%
|
2.67
|
| Selling General And Administration |
|
12.88
+82.60%
|
7.05
-10.50%
|
7.88
-20.61%
|
9.92
|
| General And Administrative Expense |
|
12.88
+82.60%
|
7.05
-10.50%
|
7.88
-20.61%
|
9.92
|
| Other Gand A |
|
12.88
+82.60%
|
7.05
-10.50%
|
7.88
-20.61%
|
9.92
|
| Total Expenses |
|
20.86
+46.37%
|
14.25
-10.82%
|
15.98
+26.93%
|
12.59
|
| Operating Income |
|
-20.86
-46.37%
|
-14.25
+10.82%
|
-15.98
-26.93%
|
-12.59
|
| Total Operating Income As Reported |
|
-20.86
-46.37%
|
-14.25
+10.82%
|
-15.98
-26.93%
|
-12.59
|
| EBITDA |
|
-20.19
-48.48%
|
-13.60
+11.28%
|
-15.33
-21.83%
|
-12.58
|
| Normalized EBITDA |
|
-19.92
-47.28%
|
-13.52
+12.11%
|
-15.39
-14.54%
|
-13.43
|
| Reconciled Depreciation |
|
0.66
+2.09%
|
0.65
+0.09%
|
0.65
+12629.76%
|
0.01
|
| EBIT |
|
-20.86
-46.37%
|
-14.25
+10.82%
|
-15.98
-26.93%
|
-12.59
|
| Total Unusual Items |
|
-0.28
-257.44%
|
-0.08
-238.33%
|
0.06
-93.39%
|
0.85
|
| Total Unusual Items Excluding Goodwill |
|
-0.28
-257.44%
|
-0.08
-238.33%
|
0.06
-93.39%
|
0.85
|
| Special Income Charges |
|
—
|
—
|
0.00
+100.00%
|
-1.00
|
| Other Special Charges |
|
—
|
—
|
—
|
1.00
|
| Net Income |
|
-20.43
-46.91%
|
-13.90
+12.89%
|
-15.96
-14.53%
|
-13.94
|
| Pretax Income |
|
-20.43
-46.91%
|
-13.90
+10.34%
|
-15.51
-32.23%
|
-11.73
|
| Net Non Operating Interest Income Expense |
|
0.33
-22.68%
|
0.42
+1.88%
|
0.42
|
0.00
|
| Interest Expense Non Operating |
|
—
|
—
|
—
|
0.00
|
| Net Interest Income |
|
0.33
-22.68%
|
0.42
+1.88%
|
0.42
|
0.00
|
| Interest Expense |
|
—
|
—
|
—
|
0.00
|
| Interest Income Non Operating |
|
0.33
-22.68%
|
0.42
+1.88%
|
0.42
|
0.00
|
| Interest Income |
|
0.33
-22.68%
|
0.42
+1.88%
|
0.42
|
0.00
|
| Other Income Expense |
|
0.10
+231.63%
|
-0.08
-238.33%
|
0.06
-93.47%
|
0.86
|
| Other Non Operating Income Expenses |
|
0.38
|
—
|
—
|
0.01
|
| Gain On Sale Of Security |
|
-0.28
-257.44%
|
-0.08
-238.33%
|
0.06
-96.96%
|
1.85
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-20.43
-46.91%
|
-13.90
+12.89%
|
-15.96
-14.53%
|
-13.94
|
| Net Income From Continuing Operation Net Minority Interest |
|
-20.43
-46.91%
|
-13.90
+10.34%
|
-15.51
-32.23%
|
-11.73
|
| Net Income From Continuing And Discontinued Operation |
|
-20.43
-46.91%
|
-13.90
+12.89%
|
-15.96
-14.53%
|
-13.94
|
| Net Income Continuous Operations |
|
-20.43
-46.91%
|
-13.90
+10.34%
|
-15.51
-32.23%
|
-11.73
|
| Net Income Discontinuous Operations |
|
—
|
0.00
+100.00%
|
-0.45
+79.45%
|
-2.21
|
| Normalized Income |
|
-20.15
-45.76%
|
-13.83
+11.16%
|
-15.56
-23.74%
|
-12.58
|
| Net Income Common Stockholders |
|
-20.43
-46.91%
|
-13.90
+12.89%
|
-15.96
-14.53%
|
-13.94
|
| Diluted EPS |
|
—
|
-12.69
+2.46%
|
-13.01
-17.95%
|
-11.03
|
| Basic EPS |
|
—
|
-12.69
+2.46%
|
-13.01
-17.95%
|
-11.03
|
| Basic Average Shares |
|
—
|
1.10
-10.64%
|
1.23
-2.83%
|
1.26
|
| Diluted Average Shares |
|
—
|
1.10
-10.64%
|
1.23
-2.83%
|
1.26
|
| Diluted NI Availto Com Stockholders |
|
-20.43
-46.91%
|
-13.90
+12.89%
|
-15.96
-14.53%
|
-13.94
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
60.24
+274.98%
|
16.06
-38.49%
|
26.12
-42.19%
|
45.18
|
| Current Assets |
|
56.46
+666.24%
|
7.37
-55.86%
|
16.69
-51.02%
|
34.08
|
| Cash Cash Equivalents And Short Term Investments |
|
55.16
+696.78%
|
6.92
-57.61%
|
16.33
-50.64%
|
33.09
|
| Cash And Cash Equivalents |
|
55.16
+696.78%
|
6.92
-57.61%
|
16.33
-50.64%
|
33.09
|
| Cash Equivalents |
|
53.40
+775.41%
|
6.10
-54.48%
|
13.40
|
—
|
| Cash Financial |
|
1.76
+113.79%
|
0.82
-71.93%
|
2.93
-91.16%
|
33.15
|
| Receivables |
|
—
|
0.00
-100.00%
|
0.04
|
0.00
|
| Other Receivables |
|
—
|
—
|
0.04
-86.60%
|
0.30
|
| Prepaid Assets |
|
0.81
+168.12%
|
0.30
+40.18%
|
0.22
-61.61%
|
0.56
|
| Restricted Cash |
|
0.10
|
0.00
|
—
|
—
|
| Assets Held For Sale Current |
|
—
|
—
|
0.00
-100.00%
|
0.16
|
| Other Current Assets |
|
0.39
+171.31%
|
0.14
+36.52%
|
0.10
-60.19%
|
0.26
|
| Total Non Current Assets |
|
3.78
-56.52%
|
8.70
-7.73%
|
9.42
-15.12%
|
11.10
|
| Net PPE |
|
0.00
-100.00%
|
0.12
-44.51%
|
0.22
-64.76%
|
0.63
|
| Gross PPE |
|
0.00
-100.00%
|
0.16
-32.49%
|
0.24
-61.22%
|
0.63
|
| Accumulated Depreciation |
|
0.00
+100.00%
|
-0.04
-80.32%
|
-0.02
-559.96%
|
-0.00
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.00
-100.00%
|
0.01
+0.00%
|
0.01
-76.69%
|
0.03
|
| Other Properties |
|
—
|
0.16
-33.78%
|
0.23
-60.87%
|
0.60
|
| Leases |
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Goodwill And Other Intangible Assets |
|
3.78
-55.90%
|
8.57
-6.85%
|
9.20
-6.41%
|
9.83
|
| Goodwill |
|
0.00
-100.00%
|
1.26
+0.00%
|
1.26
+0.00%
|
1.26
|
| Other Intangible Assets |
|
3.78
-48.28%
|
7.31
-7.94%
|
7.94
-7.35%
|
8.57
|
| Other Non Current Assets |
|
—
|
—
|
—
|
0.64
|
| Total Liabilities Net Minority Interest |
|
5.02
+291.63%
|
1.28
-52.84%
|
2.72
+1.36%
|
2.68
|
| Current Liabilities |
|
4.97
+344.15%
|
1.12
-57.48%
|
2.63
+40.29%
|
1.88
|
| Payables And Accrued Expenses |
|
1.13
+1.00%
|
1.12
-56.12%
|
2.55
+72.29%
|
1.48
|
| Current Debt And Capital Lease Obligation |
|
—
|
—
|
0.08
-49.07%
|
0.16
|
| Current Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
0.08
-49.07%
|
0.16
|
| Other Current Liabilities |
|
3.84
|
—
|
—
|
0.24
|
| Total Non Current Liabilities Net Minority Interest |
|
0.05
-71.10%
|
0.16
+92.22%
|
0.08
-89.51%
|
0.80
|
| Liabilities Heldfor Sale Non Current |
|
—
|
—
|
0.00
-100.00%
|
0.32
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
—
|
0.00
-100.00%
|
0.34
|
| Long Term Capital Lease Obligation |
|
—
|
—
|
0.00
-100.00%
|
0.34
|
| Stockholders Equity |
|
55.22
+273.54%
|
14.78
-36.82%
|
23.40
-44.94%
|
42.50
|
| Common Stock Equity |
|
55.22
+273.54%
|
14.78
-36.82%
|
23.40
-44.94%
|
42.50
|
| Capital Stock |
|
0.00
+1561.15%
|
0.00
+33.65%
|
0.00
-20.00%
|
0.00
|
| Common Stock |
|
0.00
+1561.15%
|
0.00
+33.65%
|
0.00
-20.00%
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
23.09
+1556.15%
|
1.39
+33.86%
|
1.04
-20.01%
|
1.30
|
| Ordinary Shares Number |
|
23.09
+1556.15%
|
1.39
+33.86%
|
1.04
-20.01%
|
1.30
|
| Additional Paid In Capital |
|
125.21
+94.51%
|
64.37
+9.62%
|
58.72
-5.07%
|
61.86
|
| Retained Earnings |
|
-70.01
-41.20%
|
-49.58
-40.39%
|
-35.32
-82.46%
|
-19.36
|
| Gains Losses Not Affecting Retained Earnings |
|
0.02
+361.69%
|
-0.01
-54.15%
|
-0.00
-603.78%
|
-0.00
|
| Other Equity Adjustments |
|
0.02
+361.69%
|
-0.01
-54.15%
|
-0.00
-603.78%
|
-0.00
|
| Total Equity Gross Minority Interest |
|
55.22
+273.54%
|
14.78
-36.82%
|
23.40
-44.94%
|
42.50
|
| Total Capitalization |
|
55.22
+273.54%
|
14.78
-36.82%
|
23.40
-44.94%
|
42.50
|
| Working Capital |
|
51.49
+723.97%
|
6.25
-55.55%
|
14.06
-56.34%
|
32.20
|
| Invested Capital |
|
55.22
+273.54%
|
14.78
-36.82%
|
23.40
-44.94%
|
42.50
|
| Total Debt |
|
—
|
0.00
-100.00%
|
0.08
-83.81%
|
0.50
|
| Capital Lease Obligations |
|
—
|
0.00
-100.00%
|
0.08
-83.81%
|
0.50
|
| Net Tangible Assets |
|
51.44
+728.50%
|
6.21
-56.26%
|
14.19
-56.54%
|
32.66
|
| Tangible Book Value |
|
51.44
+728.50%
|
6.21
-56.26%
|
14.19
-56.54%
|
32.66
|
| Derivative Product Liabilities |
|
0.05
-71.10%
|
0.16
+92.22%
|
0.08
-40.00%
|
0.14
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-15.21
-9.25%
|
-13.92
-3.71%
|
-13.43
+1.94%
|
-13.69
|
| Cash Flow From Continuing Operating Activities |
|
-15.21
-9.25%
|
-13.92
-8.66%
|
-12.81
-7.73%
|
-11.89
|
| Cash From Discontinued Operating Activities |
|
—
|
0.00
+100.00%
|
-0.61
+65.98%
|
-1.80
|
| Net Income From Continuing Operations |
|
-20.43
-46.91%
|
-13.90
+10.34%
|
-15.51
-32.23%
|
-11.73
|
| Depreciation Amortization Depletion |
|
0.66
+2.09%
|
0.65
+0.09%
|
0.65
+12629.76%
|
0.01
|
| Depreciation |
|
0.03
+71.86%
|
0.02
+3.14%
|
0.02
+259.05%
|
0.01
|
| Amortization Cash Flow |
|
0.63
+0.00%
|
0.63
+0.00%
|
0.63
|
0.00
|
| Depreciation And Amortization |
|
0.66
+2.09%
|
0.65
+0.09%
|
0.65
+12629.76%
|
0.01
|
| Amortization Of Intangibles |
|
0.63
+0.00%
|
0.63
+0.00%
|
0.63
|
0.00
|
| Other Non Cash Items |
|
—
|
—
|
—
|
0.36
|
| Stock Based Compensation |
|
0.30
-61.55%
|
0.77
+30.63%
|
0.59
-29.08%
|
0.84
|
| Asset Impairment Charge |
|
4.16
|
0.00
|
—
|
0.42
|
| Operating Gains Losses |
|
0.41
+429.28%
|
0.08
+164.15%
|
-0.12
+93.45%
|
-1.85
|
| Gain Loss On Investment Securities |
|
0.30
+287.27%
|
0.08
+238.33%
|
-0.06
+96.96%
|
-1.85
|
| Net Foreign Currency Exchange Gain Loss |
|
0.01
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
-0.32
+79.03%
|
-1.52
-196.52%
|
1.57
+86.22%
|
0.85
|
| Change In Prepaid Assets |
|
-0.06
+30.21%
|
-0.09
-125.04%
|
0.35
+291.03%
|
-0.18
|
| Change In Payables And Accrued Expense |
|
0.01
+100.78%
|
-1.43
-233.76%
|
1.07
+43.61%
|
0.75
|
| Change In Other Current Assets |
|
-0.27
-12004.42%
|
0.00
-98.57%
|
0.16
+160.19%
|
-0.26
|
| Change In Other Current Liabilities |
|
0.00
+100.00%
|
-0.00
-55.72%
|
-0.00
-100.28%
|
0.54
|
| Investing Cash Flow |
|
0.01
|
0.00
-100.00%
|
0.40
+113.63%
|
-2.93
|
| Cash Flow From Continuing Investing Activities |
|
0.01
|
0.00
-100.00%
|
0.08
+103.27%
|
-2.30
|
| Cash From Discontinued Investing Activities |
|
—
|
0.00
-100.00%
|
0.32
+151.65%
|
-0.63
|
| Net PPE Purchase And Sale |
|
0.01
|
0.00
+100.00%
|
-0.03
+67.97%
|
-0.11
|
| Purchase Of PPE |
|
—
|
0.00
+100.00%
|
-0.03
+67.97%
|
-0.11
|
| Sale Of PPE |
|
0.01
|
0.00
|
—
|
—
|
| Capital Expenditure |
|
—
|
—
|
-0.03
+67.97%
|
-0.11
|
| Net Business Purchase And Sale |
|
—
|
—
|
0.00
+100.00%
|
-2.19
|
| Purchase Of Business |
|
—
|
—
|
0.00
+100.00%
|
-2.19
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
—
|
-1.76
|
| Purchase Of Intangibles |
|
—
|
—
|
—
|
-1.76
|
| Net Other Investing Changes |
|
—
|
—
|
0.11
|
—
|
| Financing Cash Flow |
|
63.52
+1306.02%
|
4.52
+221.23%
|
-3.73
-16.22%
|
-3.21
|
| Cash Flow From Continuing Financing Activities |
|
63.52
+1306.02%
|
4.52
+221.23%
|
-3.73
-16.22%
|
-3.21
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
|
0.00
|
0.00
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
0.39
|
0.00
|
| Repayment Of Debt |
|
—
|
0.00
+100.00%
|
-0.39
|
0.00
|
| Long Term Debt Issuance |
|
—
|
0.00
-100.00%
|
0.39
|
0.00
|
| Long Term Debt Payments |
|
—
|
0.00
+100.00%
|
-0.39
|
0.00
|
| Net Long Term Debt Issuance |
|
—
|
0.00
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
61.72
|
0.00
+100.00%
|
-3.73
-16.22%
|
-3.21
|
| Common Stock Payments |
|
—
|
0.00
+100.00%
|
-3.73
-16.22%
|
-3.21
|
| Repurchase Of Capital Stock |
|
—
|
0.00
+100.00%
|
-3.73
-16.22%
|
-3.21
|
| Proceeds From Stock Option Exercised |
|
2.25
-50.20%
|
4.52
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
-0.45
+6.90%
|
-0.48
|
—
|
—
|
| Changes In Cash |
|
48.32
+613.71%
|
-9.41
+43.86%
|
-16.75
+15.49%
|
-19.82
|
| Effect Of Exchange Rate Changes |
|
0.02
+844.98%
|
-0.00
+36.88%
|
-0.00
-140.31%
|
0.01
|
| Beginning Cash Position |
|
6.92
-57.61%
|
16.33
-50.64%
|
33.09
-37.45%
|
52.90
|
| End Cash Position |
|
55.26
+698.24%
|
6.92
-57.61%
|
16.33
-50.64%
|
33.09
|
| Free Cash Flow |
|
-15.21
-9.25%
|
-13.92
-3.45%
|
-13.46
+2.45%
|
-13.80
|
| Interest Paid Supplemental Data |
|
0.01
|
0.00
|
—
|
—
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
—
|
—
|
| Common Stock Issuance |
|
61.72
|
0.00
|
—
|
0.00
|
| Issuance Of Capital Stock |
|
61.72
|
0.00
|
—
|
0.00
|
| Sale Of Business |
|
—
|
—
|
—
|
0.08
|
| Cash From Discontinued Financing Activities |
|
—
|
0.00
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-03-30 View
- 8-K2026-02-20 View
- 8-K2026-01-28 View
- 8-K2025-12-15 View
- 8-K2025-12-02 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 8-K2025-11-25 View
- 10-Q2025-11-13 View
- 8-K2025-11-04 View
- 42025-10-27 View
- 42025-10-27 View
- 42025-10-27 View
- 42025-10-27 View
- 42025-10-27 View
- 42025-10-27 View
- 8-K2025-10-27 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|